TherapeuticsMD, Inc.TXMDNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-27.73%
↓ 242% below average
Average (39q)
19.52%
Historical baseline
Range
High:361.19%
Low:-154.72%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -27.73% |
| Q2 2025 | 142.24% |
| Q1 2025 | -41.08% |
| Q4 2024 | 21.94% |
| Q3 2024 | 133.76% |
| Q2 2024 | -25.24% |
| Q1 2024 | 331.85% |
| Q4 2023 | -154.72% |
| Q3 2023 | -112.13% |
| Q2 2023 | 5.05% |
| Q1 2023 | 118.23% |
| Q4 2022 | -113.32% |
| Q3 2022 | -28.09% |
| Q2 2022 | 64.59% |
| Q1 2022 | 3.82% |
| Q4 2021 | -30.72% |
| Q3 2021 | 6.65% |
| Q2 2021 | 24.31% |
| Q1 2021 | -10.70% |
| Q4 2020 | 5.81% |
| Q3 2020 | 154.93% |
| Q2 2020 | -33.92% |
| Q1 2020 | -26.78% |
| Q4 2019 | -41.54% |
| Q3 2019 | 361.19% |
| Q2 2019 | 51.70% |
| Q1 2019 | -23.07% |
| Q4 2018 | 49.18% |
| Q3 2018 | -16.15% |
| Q2 2018 | 5.39% |
| Q1 2018 | -11.04% |
| Q4 2017 | -5.04% |
| Q3 2017 | 4.15% |
| Q2 2017 | 7.30% |
| Q1 2017 | -11.96% |
| Q4 2016 | -12.11% |
| Q3 2016 | 31.32% |
| Q2 2016 | -14.35% |
| Q1 2016 | -13.02% |
| Q4 2015 | 9.95% |